These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35805022)

  • 1. Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy.
    Lindgaard SC; Maag E; Sztupinszki Z; Chen IM; Johansen AZ; Jensen BV; Bojesen SE; Nielsen DL; Szallasi Z; Johansen JS
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification.
    Lindgaard SC; Sztupinszki Z; Maag E; Chen IM; Johansen AZ; Jensen BV; Bojesen SE; Nielsen DL; Hansen CP; Hasselby JP; Nielsen KR; Szallasi Z; Johansen JS
    Clin Cancer Res; 2021 May; 27(9):2592-2603. PubMed ID: 33737308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer.
    Lindgaard SC; Sztupinszki Z; Maag E; Hansen CP; Chen IM; Johansen AZ; Hasselby JP; Bojesen SE; Nielsen D; Johansen JS
    Cancer Med; 2023 Feb; 12(4):3972-3986. PubMed ID: 36250429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.
    Kruger D; Lahoud N; Yako YY; Devar J; Smith M
    PLoS One; 2022; 17(1):e0262439. PubMed ID: 35020761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection.
    Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
    Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
    J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
    Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
    Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
    Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
    BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
    Christensen TD; Maag E; Larsen O; Feltoft CL; Nielsen KR; Jensen LH; Leerhøy B; Hansen CP; Chen IM; Nielsen DL; Johansen JS
    JHEP Rep; 2023 Mar; 5(3):100648. PubMed ID: 36699667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
    Kruger D; Yako YY; Devar J; Lahoud N; Smith M
    PLoS One; 2019; 14(8):e0221169. PubMed ID: 31415645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
    Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
    Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
    Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
    Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer survival prediction via inflammatory serum markers.
    Lanki M; Seppänen H; Mustonen H; Salmiheimo A; Stenman UH; Salmi M; Jalkanen S; Haglund C
    Cancer Immunol Immunother; 2022 Sep; 71(9):2287-2292. PubMed ID: 35034144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients.
    Xiao Y; Xie Z; Shao Z; Chen W; Xie H; Qin G; Zhao N
    Medicine (Baltimore); 2017 Dec; 96(50):e9247. PubMed ID: 29390358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
    Christensen TD; Madsen K; Maag E; Larsen O; Jensen LH; Hansen CP; Markussen A; Høgdall DTS; Chen IM; Nielsen D; Johansen JS
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
    Bittoni A; Pecci F; Mentrasti G; Crocetti S; Lupi A; Lanese A; Pellei C; Ciotti C; Cantini L; Giampieri R; Lenci E; Giglio E; Bini F; Copparoni C; Meletani T; Baleani MG; Berardi R
    Ann Transl Med; 2021 Feb; 9(3):251. PubMed ID: 33708878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer.
    Rasmussen LS; Yilmaz MK; Falkmer UG; Poulsen LØ; Bøgsted M; Christensen HS; Bojesen SE; Jensen BV; Chen IM; Johansen AZ; Hansen CP; Hasselby JP; Holländer N; Nielsen SE; Andersen F; Bjerregaard JK; Pfeiffer P; Johansen JS
    Eur J Cancer; 2021 Feb; 144():72-80. PubMed ID: 33341448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.